| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Revenue | $14.4B | $14.3B | $14.2B | $13.7B | $14.3B | $3.5B |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | $1.0B |
| R&D Expense | $0.2B | $0.2B | $0.1B | $0.1B | $0.2B | $0.2B |
| SG&A Expense | $2.0B | $1.9B | $1.9B | $1.8B | $1.9B | $1.9B |
| Operating Income | $2.1B | $2.0B | $2.2B | $2.0B | $2.1B | $1.6B |
| Net Income | $1.4B | $1.6B | $1.4B | $1.3B | $1.2B | $0.3B |
| EPS (Basic) | $3.52 | $4.10 | $3.42 | $2.98 | $2.91 | $0.58 |
| EPS (Diluted) | $3.50 | $4.07 | $3.39 | $2.96 | $2.89 | $0.58 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Total Assets | $10.7B | $11.3B | $10.1B | $9.8B | $12.3B | $10.7B |
| Current Assets | $6.5B | $7.7B | $6.4B | $6.1B | $8.3B | $6.5B |
| Cash & Equivalents | $1.1B | $2.3B | $1.3B | $1.2B | $1.6B | $1.8B |
| Total Liabilities | $15.9B | $16.0B | $14.8B | $14.5B | $15.3B | $13.9B |
| Current Liabilities | $7.7B | $7.7B | $6.5B | $6.8B | $6.2B | $6.7B |
| Stockholders' Equity | $-5.4B | $-4.8B | $-4.9B | $-4.9B | $-3.6B | $-3.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.6B | $1.6B | $1.6B | $1.6B | $1.8B | $1.5B |
| Investing Cash Flow | $-0.4B | $-0.2B | $-0.2B | $-0.0B | $-0.1B | $-0.4B |
| Capital Expenditures | — | — | — | — | — | — |
| Financing Cash Flow | $-2.4B | $-0.3B | $-1.4B | $-3.7B | $0.1B | $-0.8B |